Gemfibrozil tablet/ Capsule bulk supplier for pharma manufacturers

Gemfibrozil Tablet/ Capsule 600 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet/Capsules

Available Strengths: 600 mg

Reference Brands: Lopid(US & EU)

Gemfibrozil is a fibrate that activates PPARα receptors, improving lipid metabolism. It significantly lowers triglycerides, increases HDL cholesterol, and modestly reduces LDL cholesterol. Benefits include reducing cardiovascular risk, preventing pancreatitis, and supporting long-term management of dyslipidemia, promoting overall heart health and metabolic balance.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Gemfibrozil tablets and capsules, marketed as Lopid, are approved in the US by the FDA and in the EU via EMA for treating hypertriglyceridemia. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and quality data, while the EMA ensures regional safety and manufacturing compliance. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional regulations supports timely approval, safe use, and worldwide availability, helping patients manage dyslipidemia effectively and reduce cardiovascular risk across regions.

Gemfibrozil Tablet/ Capsule — third party manufacturing & bulk supply

Gemfibrozil Tablet/ Capsule 600 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Gemfibrozil Tablet/ Capsule is supplied as Tablet/Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Gemfibrozil Tablet/ Capsule listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Gemfibrozil Tablet/ Capsule →

Back to Listing

Frequently Asked Questions

Gemfibrozil tablet/ Capsule is listed as Tablet/Capsules in 600 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Gemfibrozil tablet/ Capsule is referenced against Lopid(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.